Home Boronic Acids 1370008-65-3
1370008-65-3,MFCD22683474
Catalog No.:AA0012LX

1370008-65-3 | 2-Cyclopenten-1-one, 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98+%
in stock  
$51.00   $36.00
- +
250mg
98+%
in stock  
$85.00   $60.00
- +
1g
98+%
in stock  
$180.00   $126.00
- +
5g
98+%
in stock  
$536.00   $376.00
- +
10g
95%
in stock  
$1,030.00   $721.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA0012LX
Chemical Name:
2-Cyclopenten-1-one, 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS Number:
1370008-65-3
Molecular Formula:
C11H17BO3
Molecular Weight:
208.0619
MDL Number:
MFCD22683474
SMILES:
O=C1CCC(=C1)B1OC(C(O1)(C)C)(C)C
Properties
Computed Properties
 
Complexity:
315  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
3  
Rotatable Bond Count:
1  

Downstream Synthesis Route

[1]CurrentPatentAssignee:NIMBUSTHERAPEUTICSINC;CHARLESRIVERLABORATORIESINTERNATIONALINC;NIMBUSSATURN-US2021/78996,2021,A1Locationinpatent:Paragraph0979;0981

[2]CurrentPatentAssignee:BIOCONLIMITED;BRISTOL-MYERSSQUIBBCO-US2019/185469,2019,A1Locationinpatent:Paragraph0564-0565

[3]CurrentPatentAssignee:Wang,Zhong;Smith,EmilieD.;Veal,JamesM.;Huang,KennethH.;Atkinson,RobertN.;Jiang,Rong-US2012/77814,2012,A1Locationinpatent:Page/Pagecolumn55

[4]CurrentPatentAssignee:TETRADISCOVERYPARTNERS-WO2014/66659,2014,A1Locationinpatent:Paragraph0732

[5]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2020/128768,2020,A1Locationinpatent:Page/Pagecolumn218-219

[6]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US9242996,2016,B2Locationinpatent:Page/Pagecolumn93;94;95

[7]CurrentPatentAssignee:ASSEMBLYBIOSCIENCES,INC.-WO2018/53157,2018,A1Locationinpatent:Page/Pagecolumn77;78

[1]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-US9242996,2016,B2

[2]CurrentPatentAssignee:ASSEMBLYBIOSCIENCES,INC.-WO2018/53157,2018,A1

[3]CurrentPatentAssignee:Wang,Zhong;Smith,EmilieD.;Veal,JamesM.;Huang,KennethH.;Atkinson,RobertN.;Jiang,Rong-US2012/77814,2012,A1

[4]CurrentPatentAssignee:ROCHEHOLDINGAG-US2018/282328,2018,A1

[5]CurrentPatentAssignee:BIOCONLIMITED;BRISTOL-MYERSSQUIBBCO-US2019/185469,2019,A1

[6]CurrentPatentAssignee:NOVARTISAG;Novartis(w/oSandoz)-WO2020/128768,2020,A1

[7]CurrentPatentAssignee:NIMBUSTHERAPEUTICSINC;CHARLESRIVERLABORATORIESINTERNATIONALINC;NIMBUSSATURN-US2021/78996,2021,A1

[8]Gaube,Gregory;Leitch,DavidC.;PipaonFernandez,Nahiane[NewJournalofChemistry,2021,vol.45,#43,p.20095-20098]

[1]CurrentPatentAssignee:Wang,Zhong;Smith,EmilieD.;Veal,JamesM.;Huang,KennethH.;Atkinson,RobertN.;Jiang,Rong-US2012/77814,2012,A1

[1]CurrentPatentAssignee:Wang,Zhong;Smith,EmilieD.;Veal,JamesM.;Huang,KennethH.;Atkinson,RobertN.;Jiang,Rong-US2012/77814,2012,A1

[1]CurrentPatentAssignee:Wang,Zhong;Smith,EmilieD.;Veal,JamesM.;Huang,KennethH.;Atkinson,RobertN.;Jiang,Rong-US2012/77814,2012,A1

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1370008-65-3 Molecular Formula|1370008-65-3 MDL|1370008-65-3 SMILES|1370008-65-3 2-Cyclopenten-1-one, 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-